NK do not express MHC so they are unable to induce graft-versus-host disease; therefore, allogeneic or cell lines cells can be infused into patients and not depend solely on autologous cells. Another advantage is that NKs release different cytokine profile which makes them less susceptible to adverse effects such as CRS or neurotoxicity. This evidence concerns the gene HLA-C and graft versus host disease.